Dr Amol Akhade (@suyogcancer) 's Twitter Profile
Dr Amol Akhade

@suyogcancer

Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists

ID: 1135941148378247168

linkhttp://suyogcancerclincs.com calendar_today04-06-2019 16:07:29

6,6K Tweet

3,3K Followers

125 Following

Dr Amol Akhade (@suyogcancer) 's Twitter Profile Photo
Dr Amol Akhade
@suyogcancer

4 months ago

One more trial to show that u can not give IO drugs along with Chemoradiation in stage IIIB NSCLC . Checkmate 73L . Concurrent Nivo plus cCRT followed by Nivo plus IPI or Nivo alone vs Pacific arm ( cCRT followed by Durva ) failed to show PFS benifit. Press release.

One more trial to show that u can not give IO drugs along with Chemoradiation in stage IIIB NSCLC . Checkmate 73L . Concurrent Nivo plus cCRT followed by Nivo plus IPI or Nivo alone vs Pacific arm ( cCRT followed by Durva ) failed to show PFS benifit. Press release.